Carteolol: preliminary study on ocular pressure-reducing action.
The authors studied the pressure-reducing action of a new beta-blocking agent (carteolol) in a group of subjects affected with open angle glaucoma. The drug was efficacious in all cases treated and did not show any noteworthy side effects.